Details for Patent: 6,136,794
✉ Email this page to a colleague
Summary for Patent: 6,136,794
Title: | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
Abstract: | A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of a GPIIb/IIIa receptor antagonist or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin. A method for inhibiting platelet aggregation in a mammal comprising administering to the mammal a safe and therapeutically effective amount of (2-S-(n-butylsulfonylamino)-3[4-(piperidin-4-yl)butyloxyphenyl]-propionic acid or a pharmaceutically acceptable salt thereof and a safe and therapeutically effective amount of low molecular weight heparin. |
Inventor(s): | Cook; Jacquelynn J. (Collegeville, PA), Gould; Robert J. (Green Lane, PA), Sax; Frederic L. (Villanova, PA) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 09/240,429 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,136,794 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 6,136,794
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,136,794
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2350699 | ⤷ Try a Trial | |||
Australia | 740941 | ⤷ Try a Trial | |||
Canada | 2318215 | ⤷ Try a Trial | |||
European Patent Office | 1068172 | ⤷ Try a Trial | |||
United Kingdom | 9809793 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |